Evotec SE (EVO) Stock Forecast

NASDAQ: EVOAnalyst ratings, price target and estimates.

EVO analyst forecast

as of October 17, 2026
Analyst consensus
Buy
4.00 / 5 from 3 analysts
Price target
$4.24
average of analyst targets
Upside to target
+207.3%
from the latest close
Next earnings
—
52-week range
$1.35 – $4.15

EVO analyst ratings

3 analysts
Strong buy
133%
Buy
133%
Hold
133%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

EVO price target

Price $1.38Target $4.24
52-week low $1.3552-week high $4.15

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

EVO earnings per share estimates

Evotec SE EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.32−$0.38−$0.25−$0.12−162.5%2
Current fiscal year (2026)−$1.48−$1.51−$1.44−$0.29−408.6%2
Next fiscal year (2027)$0.07$0.07$0.07−$1.48+104.8%1

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

EVO revenue estimates

Evotec SE revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$138.7M$133.0M$144.4M−15.4%2
Current fiscal year (2026)$598.8M$578.0M$681.0M−24.1%8
Next fiscal year (2027)$721.4M$629.0M$966.4M+20.5%9

EVO EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

EVO revenue: reported and forecast

Reported revenueEstimate (average; low–high)

EVO EPS estimate revisions

Evotec SE EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.20−$0.36−$0.25−$0.25−$0.32+53.7%0 up · 2 down
Current fiscal year (2026)−$1.10−$1.64−$1.44−$1.44−$1.48+33.5%0 up · 2 down
Next fiscal year (2027)−$0.15−$0.15−$0.34−$0.38$0.07−145.2%0 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

EVO earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; EVO beat in 5 of 12.

What analysts expect from EVO

3 analysts cover Evotec; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $4.24, 207.3% above the latest close of $1.38. Analysts expect earnings of −$1.48 per share for 2026, −408.6% from a year earlier. For 2027 the average estimate is $0.07 per share on revenue of $721.4 million. Evotec beat the EPS estimate in 5 of the last 12 quarters.

Related: EVO income statement, EVO key metrics, EVO chart. See the EVO stock overview for the latest quote and news.

EVO forecast FAQ

What is Evotec's price target?

The average analyst price target for Evotec is $4.24, 207.3% above the latest close of $1.38.

Is Evotec a buy, hold or sell?

Of 3 analysts covering Evotec, 1 rate it a strong buy, 1 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Evotec's EPS forecast?

Analysts forecast −$1.48 per share for 2026 (range −$1.51 to −$1.44); for 2027 the estimate is $0.07.

What is Evotec's revenue forecast?

The average revenue estimate for 2026 is $598.8 million, growth of −24.1%; for 2027 it is $721.4 million.

Does Evotec usually beat earnings estimates?

Evotec reported EPS at or above the analyst estimate in 5 of the last 12 quarters.

Drug Manufacturers - Specialty & Generic: forecast